Editorial |

Living With Uncertainty in the Intensive Care Unit:  Should Patients With Sepsis Be Treated With Steroids?

Roman Jaeschke, MD, MSc; Derek C. Angus, MD, MPH
JAMA. 2009;301(22):2388-2390. doi:10.1001/jama.2009.829.
Text Size: A A A
Published online


Physicians who practiced medicine 25 years ago likely remember the use of high-dose intravenous steroids, such as 1-g boluses of methylprednisolone, for septic shock. The practice was fueled by anecdotes of miraculous recoveries, but large randomized trials failed to demonstrate benefit and raised the specter of possible harm. Steroids were abandoned and lay dormant for years, until recent studies suggested that septic shock may be exacerbated by relative adrenal insufficiency and that smaller dose of steroids for longer periods of time may be beneficial. In 2002, in a multicenter French study, Annane et al1 reported lower mortality among patients in septic shock who were randomized to a 1-week course of low-dose steroids. This study ignited such rapid interest in steroids that the United States temporarily ran out of hydrocortisone. For those who lament the usually slow adoption of evidence into clinical practice, this event was a marked departure from the norm. Subsequent meta-analyses, systematic reviews, and professional society guidelines all echoed the notion that vasopressor-dependent septic shock should be treated with corticosteroids.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 8

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles